Literature DB >> 3766845

Clear cell cribriform hyperplasia of prostate. Report of 10 cases.

A G Ayala, J R Srigley, J Y Ro, F W Abdul-Karim, D E Johnson.   

Abstract

We report 10 patients with clear cell cribriform hyperplasia of the prostate. Their ages ranged from 62 to 87 years, with a mean of 72 years. The clinical diagnosis in all patients was benign nodular hyperplasia; all the patients are alive and have shown no evidence of recurrent disease. Follow-ups ranged from 1 month to 7 years (median: 12.5 months; mean: 24.6 months). Pathologically, this lesion has a cribriform arrangement of clear cells with a complex papillary growth simulating the cribriform pattern of prostatic carcinoma. In fact, in five of the 10 cases, the referring diagnosis was either carcinoma or possible carcinoma. Cytologically, however, there is no nuclear atypia, mitosis, or prominent nucleoli, and typically there is a double epithelial cell layer at the periphery of the involved acini. In summary, clear cell cribriform hyperplasia is a benign hyperplastic process with a complex papillary-cribriform structure and should not be confused with prostatic carcinoma. The key feature for the diagnosis is the preservation of nodular configuration with a bland cytology and double cell layer lining the involved acini.

Entities:  

Mesh:

Year:  1986        PMID: 3766845     DOI: 10.1097/00000478-198610000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Treatment of benign prostatic hyperplasia with 5-alpha-reductase inhibitor: morphological changes in patients who fail to respond.

Authors:  R Montironi; M Valli; G Fabris
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

Review 2.  [Non-neoplastic alterations of the prostate. Why should pathologists know them?].

Authors:  A Erbersdobler
Journal:  Pathologe       Date:  2013-09       Impact factor: 1.011

Review 3.  The benign mimickers of prostatic acinar adenocarcinoma.

Authors:  Yuqiao Xu; Yingmei Wang; Ru Zhou; Haiyang Li; Hong Cheng; Zhe Wang; Jing Zhang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

4.  Atypical hyperplasia in prostates of 20 to 40 year old men.

Authors:  P N Brawn; V O Speights; J U Contin; R J Bayardo; D L Kuhl
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

5.  Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes.

Authors:  O I Turhan; N E Aydin; O Sariyüce; S Ozkan
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 6.  Precursor lesions to prostatic adenocarcinoma.

Authors:  Jonathan I Epstein
Journal:  Virchows Arch       Date:  2008-12-02       Impact factor: 4.064

7.  Metastatic prostatic stromal sarcoma: A challenging diagnosis on fine-needle aspiration with broad differential diagnosis.

Authors:  Muhammad Siddique Khurram; Ghassan Tranesh; Ramen Sakhi; Ameer Hamza; Warda Ibrar; Roohi Bano
Journal:  Cytojournal       Date:  2017-06-20       Impact factor: 2.091

8.  Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients.

Authors:  Sezim Agizamhan; Feng Qu; Ning Liu; Jing Sun; Wei Xu; Lihua Zhang; Hongqian Guo; Weidong Gan
Journal:  BMC Urol       Date:  2018-06-11       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.